Valuation: Rohto Pharmaceutical Co.,Ltd.

Market Cap 644B 4.08B 3.63B 3.36B 3.04B 5.73B 385B 5.8B 40.32B 15.82B 202B 15.29B 14.97B P/E 2027 *
17.9x
P/E 2028 * 16.9x
Enterprise Value 583B 3.69B 3.29B 3.05B 2.76B 5.19B 348B 5.25B 36.51B 14.33B 183B 13.85B 13.56B EV / Sales 2027 *
1.57x
EV / Sales 2028 * 1.45x
Free-Float
84.71%
Yield 2027 *
1.73%
Yield 2028 * 1.83%
1 day-1.45%
1 week-1.77%
Current month+1.51%
1 month+2.57%
3 months+19.81%
6 months+22.17%
Current year+8.50%
1 week 2,834
Extreme 2834
2,997
1 month 2,676
Extreme 2676
2,997
Current year 2,218.5
Extreme 2218.5
3,122
1 year 2,218.5
Extreme 2218.5
3,122
3 years 1,964.5
Extreme 1964.5
3,688
5 years 1,515
Extreme 1515
4,117
10 years 794
Extreme 794
4,117
Manager TitleAgeSince
Chief Executive Officer 70 01/06/2019
President 64 26/06/2025
Director of Finance/CFO 62 01/03/2022
Director TitleAgeSince
Chairman 70 01/06/2009
Director/Board Member 71 01/06/2010
Director/Board Member 62 01/06/2011
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%-1.77%+14.84%-16.82% 4.14B
+2.66%+3.88%+60.04%+125.48% 1,133B
+1.91%+3.86%+36.34%+73.76% 621B
-0.02%-0.15%+23.74%+95.51% 503B
-0.34%+2.87%+39.25%+64.43% 379B
+2.10%+5.09%+74.16%+47.63% 370B
+1.50%+1.89%+22.33%+51.81% 292B
+1.93%+0.96%+2.23%+26.93% 262B
+1.88%+2.47%+50.26%+62.88% 237B
+1.46%-1.39%+27.77%+100.09% 190B
Average +1.18%+3.12%+35.10%+63.17% 399.21B
Weighted average by Cap. +1.64%+3.73%+42.39%+83.70%

Financials

2027 *2028 *
Net sales 372B 2.36B 2.1B 1.94B 1.76B 3.31B 222B 3.35B 23.3B 9.14B 117B 8.83B 8.65B 390B 2.46B 2.2B 2.03B 1.84B 3.47B 233B 3.51B 24.38B 9.57B 122B 9.25B 9.05B
Net income 36.42B 230M 205M 190M 172M 324M 21.74B 328M 2.28B 894M 11.43B 864M 846M 38.54B 244M 217M 201M 182M 343M 23.01B 347M 2.41B 946M 12.09B 915M 896M
Net Debt -60.89B -385M -343M -318M -288M -542M -36.35B -548M -3.81B -1.5B -19.11B -1.45B -1.42B -79.79B -505M -450M -416M -377M -710M -47.63B -718M -4.99B -1.96B -25.04B -1.89B -1.85B
Projected Income Statement - Annual - Rohto Pharmaceutical Co.,Ltd.
Logo Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of eye care (eye drops, eyewash), skin care (external medications, lip balm, sunscreen, functional cosmetics), oral medication (gastrointestinal medicines, herbal medicines, supplements), and other products and services (in vitro diagnostic reagents) in the health and beauty care field. The Company operates through four regional segments. The Japan segment manufactures and sells eye care, skin care, oral medication, and other products (services). The Americas segment and the Europe segment mainly manufacture and sell skin care products (services). The Asia segment mainly manufactures and sells eye care and skin care products (services), as well as oral medication products (services).
Employees
9,292
Date Price Change Volume
22/10/26 ¥2,851.50 -1.45% 1,402,900
21/10/26 ¥2,893.50 -0.67% 689,100
20/10/26 ¥2,913.00 +0.02% 700,800
19/10/26 ¥2,912.50 -1.15% 994,800
16/10/26 ¥2,946.50 +1.50% 1,163,000
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Rohto Pharmaceutical Co.,Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
2,893.50JPY
Average target price
3,326.36JPY
Spread / Average Target
+14.96%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Rohto Pharmaceutical Co.,Ltd.
  1. Stock Market
  2. Stocks
  3. 4527 Stock